Funder
Foundation for the National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Goss PE, Ingle JN, Ales-Martinez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al (2011) Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364(25):2381–2391
2. Gatti-Mays ME, Venzon D, Galbo CE, Singer A, Reynolds J, Makariou E, Kallakury B, Heckman-Stoddard BM, Korde L, Isaacs C et al (2016) Exemestane use in postmenopausal women at high risk for invasive breast cancer: evaluating biomarkers of efficacy and safety. CancerPrevRes(Phila) 9(3):225–233
3. Breast Cancer Risk Reduction [https://www2.tri-kobe.org/nccn/guideline/breast/english/breast_risk.pdf]
4. Chouinard S, Pelletier G, Bélanger A, Barbier O (2005) Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium. Endocr Res 30(4):717–725
5. Lazarus P, Zheng Y, Aaron Runkle E et al (2006) Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes. Pharmacogenet Genomics 15(11):769–778
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献